← Back to Search

Personalized Treatment vs Cognitive Behavioral Therapy for Eating Disorders (PT Trial)

N/A
Waitlist Available
Led By Cheri A Levinson, PhD
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-65
Meets criteria for DSM-5 defined AN, BN, BED, or OSFED (Atypical AN and Atypical BN)
Must not have
Medically Compromised Status including extremely low weight - less than or equal to 75% median BMI for age, sex, and height
Over 65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new, personalized treatment for eating disorders (ED), which may be more effective than the current gold-standard treatment. The study goals are to develop and test the new treatment, and to see if it works by targeting specific areas identified in each individual's network.

Who is the study for?
This trial is for adults aged 18-65 with an eating disorder as defined by the DSM-5, including Anorexia Nervosa (AN), Bulimia Nervosa (BN), Binge Eating Disorder (BED), or Other Specified Feeding or Eating Disorder (OSFED). Participants should not be in any other psychological treatment for their eating disorder and must have a stable weight above 75% of the median BMI for their age, sex, and height.
What is being tested?
The study compares two treatments: Network Informed Personalized Treatment (NA-PT) designed specifically based on individual patterns versus Enhanced Cognitive Behavioral Therapy (CBT-E), which is a current standard therapy. The goal is to see if personalized treatment can lead to better outcomes like symptom improvement and quality of life.
What are the potential side effects?
Since this trial involves psychological therapies rather than medication, side effects are not typical in the same way as drug trials. However, participants may experience emotional discomfort or distress while discussing sensitive topics related to their eating disorders.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been diagnosed with an eating disorder according to DSM-5.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My weight is very low for my age, sex, and height.
Select...
I am over 65 years old.
Select...
I am under 18 years old.
Select...
I do not have an eating disorder as defined by DSM-5.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Clinical Impairment using the Clinical Impairment Assessment
Change in Eating Disorder Symptoms using the Eating Disorder Examination Questionnaire
Change in Quality of Life using the Quality of Life Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Personalized Treatment for Eating DisordersExperimental Treatment1 Intervention
Participants will complete 3 sessions of education about the treatment while completing 2 weeks of mobile application questions. After completion of treatment education and mobile application questions, participants will complete 17 sessions of personalized treatment for eating disorders.
Group II: Cognitive Behavioral Therapy for Eating DisordersActive Control1 Intervention
Participants will complete 3 sessions of education about the treatment while completing 2 weeks of mobile application questions. After completion of treatment education and mobile application questions, participants will complete 17 sessions of Cognitive Behavioral Therapy for Eating Disorders.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,741,962 Total Patients Enrolled
University of LouisvilleLead Sponsor
348 Previous Clinical Trials
77,298 Total Patients Enrolled
Cheri A Levinson, PhDPrincipal InvestigatorUniversity of Louisville
2 Previous Clinical Trials
450 Total Patients Enrolled

Media Library

Cognitive Behavioral Therapy for Eating Disorders Clinical Trial Eligibility Overview. Trial Name: NCT05195840 — N/A
Anorexia nervosa Research Study Groups: Personalized Treatment for Eating Disorders, Cognitive Behavioral Therapy for Eating Disorders
Anorexia nervosa Clinical Trial 2023: Cognitive Behavioral Therapy for Eating Disorders Highlights & Side Effects. Trial Name: NCT05195840 — N/A
Cognitive Behavioral Therapy for Eating Disorders 2023 Treatment Timeline for Medical Study. Trial Name: NCT05195840 — N/A
Anorexia nervosa Patient Testimony for trial: Trial Name: NCT05195840 — N/A
~22 spots leftby Dec 2025